Although evaluations of the two miRNAs and their target genes expression in larger populations are still needed, our results indicate that hsa-miR-133a-3p, miR-1-3p, GOLPH3 and JUP are functional drivers of PCa and may be their combination is a promising diagnostic biomarker panel for prostate cancer. The gene discussed is JUP; the disease is prostate cancer.